Pharming Group NV (PHARM) — Free Cash Flow Generation Index

Latest as of September 2025: 1.00x

Pharming Group NV (PHARM) has a Free Cash Flow Generation Index of 1.00x as of September 2025. Free cash flow of €31.96 Million represents 1% of operating cash flow (€32.03 Million). Read PHARM liabilities breakdown for a breakdown of total debt and financial obligations.

FCF Generation Index

1.00x
Free Cash Flow / Operating CF

Free Cash Flow

€31.96 Million
EUR

Operating Cash Flow

€32.03 Million
EUR

Capital Expenditures

€70.00K
EUR

Pharming Group NV Free Cash Flow Generation Index (2017–2022)

Historical FCF Generation Index trend for Pharming Group NV across 6 annual periods. Explore PHARM capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.

Annual Free Cash Flow Generation for Pharming Group NV (2017–2022)

Year-by-year Free Cash Flow Generation Index for Pharming Group NV. For the full company profile including market capitalisation, see PHARM stock market capitalisation.

Year FCG Index Free Cash Flow (EUR) Operating CF Capital Expenditures YoY Change
2022 0.91x €20.92 Million €22.90 Million €1.98 Million ▲ +63.7%
2021 0.56x €20.17 Million €36.13 Million €15.96 Million ▼ -31.8%
2020 0.82x €74.51 Million €90.98 Million €16.47 Million ▲ +24.3%
2019 0.66x €49.11 Million €74.56 Million €25.44 Million ▼ -27.3%
2018 0.91x €41.87 Million €46.19 Million €4.31 Million ▲ +7.7%
2017 0.84x €38.59 Million €45.84 Million €7.25 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).